Press Release

Global Hormonal Contraceptives Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026

The global “hormonal contraceptives market” is projected to reach a value of USD 26.6 billion by 2026, with a notable CAGR of 5.8% during the forecast period 2019 to 2026. This is owing to the unmet needs for contraceptives worldwide, especially in developing nations. The market was valued at USD 16.7 billion in 2018. The World Health Organization estimated a rise in the utilization of modern contraceptives from 54% in 1990 to about 57.4% in 2015. This is attributable to the easy availability and user reliability of contraceptive products all over the world. Such factors are likely to add impetus to the hormonal contraceptives market size in the forecast duration.

Leading Players operating in the Latest Report Analysis Hormonal Contraceptives Market are: 

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Piramal Enterprises Ltd
  • Novartis AG
  • Teva Pharmaceutical Industries
  • Janssen Pharmaceuticals, Inc.
  • Allergan
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Mylan N.V.

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Recent industry developments such as mergers & acquisitions
    • regulatory scenario for key countries
    • Fertility Statistics for Key Countries, 2018
    • Reimbursement Scenario
    • New Product Launches
  • Global Hormonal Contraceptives Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Pills
      • Injectable
      • Vaginal Ring
      • Intrauterine Device
      • Implants
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Channel
      • Public Channel & NGOs
      • Others
    • Market Analysis, Insights and Forecast – By Country
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa

Related Reports:

 

Surgical Robots Market is Likely to Rise at a Staggering 21.4% CAGR; Advent of Minimally Invasive Robot-assisted Surgeries to Favor Growth, says Fortune Business Insights

Dermal Fillers Market to reach US$ 6,303.2 Mn by 2026, exhibiting a CAGR of 7.8% | Fortune Business Insights

Immunology Market to Reach US$ 143,833.2 Mn by 2026; Improvements in Drug Efficacies Will Enable Growth, says Fortune Business Insights

 

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close